HomeCompareONPH vs EQR

ONPH vs EQR: Dividend Comparison 2026

ONPH yields 2469.14% · EQR yields 4.73%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ONPH wins by $71690433869.05M in total portfolio value
10 years
ONPH
ONPH
● Live price
2469.14%
Share price
$0.08
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$71690433869.09M
Annual income
$66,400,343,104,095,020.00
Full ONPH calculator →
EQR
EQR
● Live price
4.73%
Share price
$58.58
Annual div
$2.77
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.5K
Annual income
$3,819.61
Full EQR calculator →

Portfolio growth — ONPH vs EQR

📍 ONPH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodONPHEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ONPH + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ONPH pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ONPH
Annual income on $10K today (after 15% tax)
$209,876.54/yr
After 10yr DRIP, annual income (after tax)
$56,440,291,638,480,770.00/yr
EQR
Annual income on $10K today (after 15% tax)
$401.93/yr
After 10yr DRIP, annual income (after tax)
$3,246.67/yr
At 15% tax rate, ONPH beats the other by $56,440,291,638,477,520.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ONPH + EQR for your $10,000?

ONPH: 50%EQR: 50%
100% EQR50/50100% ONPH
Portfolio after 10yr
$35845216934.57M
Annual income
$33,200,171,552,049,420.00/yr
Blended yield
92.62%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

ONPH
No analyst data
Altman Z
-181.2
Piotroski
1/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+20.1% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ONPH buys
0
EQR buys
0
No recent congressional trades found for ONPH or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricONPHEQR
Forward yield2469.14%4.73%
Annual dividend / share$2.00$2.77
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$71690433869.09M$40.5K
Annual income after 10y$66,400,343,104,095,020.00$3,819.61
Total dividends collected$71320494496.27M$16.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: ONPH vs EQR ($10,000, DRIP)

YearONPH PortfolioONPH Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$257,614$246,913.58$11,248$547.57+$246.4KONPH
2$6,220,347$5,944,700.13$12,701$666.53+$6.21MONPH
3$140,806,183$134,150,411.83$14,405$814.59+$140.79MONPH
4$2,988,682,073$2,838,019,457.81$16,413$999.84+$2988.67MONPH
5$59,495,451,401$56,297,561,582.68$18,795$1,232.92+$59495.43MONPH
6$1,111,053,579,695$1,047,393,446,695.76$21,639$1,527.95+$1111053.56MONPH
7$19,468,874,566,651$18,280,047,236,377.10$25,057$1,903.80+$19468874.54MONPH
8$320,195,562,728,668$299,363,866,942,351.70$29,197$2,385.87+$320195562.70MONPH
9$4,944,010,060,747,097$4,601,400,808,627,422.00$34,250$3,008.70+$4944010060.71MONPH
10$71,690,433,869,094,420$66,400,343,104,095,020.00$40,467$3,819.61+$71690433869.05MONPH

ONPH vs EQR: Complete Analysis 2026

ONPHStock

Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.

Full ONPH Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this ONPH vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ONPH vs SCHDONPH vs JEPIONPH vs OONPH vs KOONPH vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.